# ITM and Radiopharm sign supply agreement for n.c.a. Lutetium-177

ITM Isotope Technologies Munich SE signed a supply agreement to provide Radiopharm Theranostics with non-carrier-added Lutetium-177 for use in Radiopharm's clinical pipeline of radiopharmaceutical cancer treatments.

- Type: Contract
- Announced: 2025-05-19
- Status: announced
- Products: n.c.a. Lutetium-177, radiopharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ITM Isotope Technologies Munich SE](https://endata.com/companies/71728.md) (supplier)
- [Radiopharm Theranostics](https://endata.com/companies/84821.md) (customer)

## Sources

- [itm-radiopharma.com](https://www.itm-radiopharma.com/news/press-releases/press-releases-detail/itm-and-radiopharm-sign-supply-agreement-for-nca-lutetium-177-725/), 2025-05-19: "Ensuring supply of key isotopes continues to be a priority for our team, allowing us to accelerate our clinical programs."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.